179 related articles for article (PubMed ID: 15239334)
1. [Cyclooxygenase 2 inhibitors and cancer chemoprevention].
Masmoudi A; Le Chevalier T; Sabatier L; Soria JC
Bull Cancer; 2004 May; 91 Spec No():S77-84. PubMed ID: 15239334
[TBL] [Abstract][Full Text] [Related]
2. [Cyclooxygenase 2 inhibitors and cancer chemoprevention].
Masmoudi A; Chevalier TL; Sabatier L; Soria JC
Bull Cancer; 2004 May; 91 Suppl 2():S77-84. PubMed ID: 15899630
[TBL] [Abstract][Full Text] [Related]
3. [Cyclooxygenase 2 inhibitors and lung carcinoma].
Spano JP; Chouahnia K; Morère JF
Bull Cancer; 2004 May; 91 Spec No():S109-12. PubMed ID: 15239338
[TBL] [Abstract][Full Text] [Related]
4. [Cyclooxygenase 2 inhibitors and colorectal cancer].
Bernardeau-Mozer M; Chaussade S
Bull Cancer; 2004 May; 91 Spec No():S89-98. PubMed ID: 15239336
[TBL] [Abstract][Full Text] [Related]
5. [Cyclo-oxygenase 2 inhibitors and cancer].
André T; Soria JC
Bull Cancer; 2004 May; 91 Spec No():S59-60. PubMed ID: 15239332
[No Abstract] [Full Text] [Related]
6. Celecoxib: a potent cyclooxygenase-2 inhibitor in cancer prevention.
Kismet K; Akay MT; Abbasoglu O; Ercan A
Cancer Detect Prev; 2004; 28(2):127-42. PubMed ID: 15068837
[TBL] [Abstract][Full Text] [Related]
7. [Cyclooxygenase 2 inhibitors and adenomatous polyposis coli].
Florent C; Meary N
Bull Cancer; 2004 May; 91 Spec No():S85-8. PubMed ID: 15239335
[TBL] [Abstract][Full Text] [Related]
8. [Cyclooxygenase 2 inhibitors and urologic and gynaecologic cancers].
Eschwege P
Bull Cancer; 2004 May; 91 Spec No():S113-6. PubMed ID: 15239339
[TBL] [Abstract][Full Text] [Related]
9. [Cyclooxygenase 2 inhibitors and colorectal cancer].
Bernardeau-Mozer M; Chaussade S
Bull Cancer; 2004 May; 91 Suppl 2():S89-98. PubMed ID: 15899632
[TBL] [Abstract][Full Text] [Related]
10. Non-COX-2 targets and cancer: expanding the molecular target repertoire of chemoprevention.
Kashfi K; Rigas B
Biochem Pharmacol; 2005 Oct; 70(7):969-86. PubMed ID: 15949789
[TBL] [Abstract][Full Text] [Related]
11. Hepatocellular carcinoma: is there a potential for chemoprevention using cyclooxygenase-2 inhibitors?
Koga H
Cancer; 2003 Aug; 98(4):661-7. PubMed ID: 12910508
[TBL] [Abstract][Full Text] [Related]
12. Role of COX-2 selective inhibitors for prevention and treatment of cancer.
Amir M; Agarwal HK
Pharmazie; 2005 Aug; 60(8):563-70. PubMed ID: 16124396
[TBL] [Abstract][Full Text] [Related]
13. Why cyclooxygenase-2 inhibition plus chemotherapy?
Sweeney CJ
Am J Clin Oncol; 2003 Aug; 26(4):S122-5. PubMed ID: 12902869
[TBL] [Abstract][Full Text] [Related]
14. Herbal medicine, cancer prevention and cyclooxygenase 2 inhibition.
Izzo AA; Capasso F
Trends Pharmacol Sci; 2003 May; 24(5):218-9. PubMed ID: 12767718
[No Abstract] [Full Text] [Related]
15. Immune restoration in head and neck cancer patients via cyclooxygenase inhibition: an update.
Lang S; Zeidler R
Int J Immunopathol Pharmacol; 2003; 16(2 Suppl):41-8. PubMed ID: 14552703
[TBL] [Abstract][Full Text] [Related]
16. Polyamines and cancer: old molecules, new understanding.
Gerner EW; Meyskens FL
Nat Rev Cancer; 2004 Oct; 4(10):781-92. PubMed ID: 15510159
[TBL] [Abstract][Full Text] [Related]
17. Cancer prevention: a new era beyond cyclooxygenase-2.
Rigas B; Kashfi K
J Pharmacol Exp Ther; 2005 Jul; 314(1):1-8. PubMed ID: 15805430
[TBL] [Abstract][Full Text] [Related]
18. Current application of selective COX-2 inhibitors in cancer prevention and treatment.
Stratton MS; Alberts DS
Oncology (Williston Park); 2002 May; 16(5 Suppl 4):37-51. PubMed ID: 12102579
[TBL] [Abstract][Full Text] [Related]
19. [Cyclooxygenase 2 and carcinogenesis].
Rodrigues S; Bruyneel E; Rodrigue CM; Shahin E; Gespach C
Bull Cancer; 2004 May; 91 Spec No():S61-76. PubMed ID: 15239333
[TBL] [Abstract][Full Text] [Related]
20. Cyclooxygenase-2 and 5-lipoxygenase converging functions on cell proliferation and tumor angiogenesis: implications for cancer therapy.
Romano M; Claria J
FASEB J; 2003 Nov; 17(14):1986-95. PubMed ID: 14597668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]